Literature DB >> 27260584

Surgical correction of bifid nose.

Ali Tawfik1, Hossam Elsayed El-Sisi2, Ahmed Musaad Abd El-Fattah1.   

Abstract

OBJECTIVES: Evaluation of the aesthetic outcome and functional aspect after surgical correction of bifid nose by combined Millard forked flap with external rhinoplasty
BACKGROUND: Bifid nose is a rare congenital anomaly that results during facial development but the explicit mechanism is not clearly understood. Clinical findings are quite variable with a wide range of severity. Surgical correction still represents great challenge to facial plastic surgeons; extensive deformities in many cases, rarity of condition and paucity of publications are contributing factors.
METHODS: Surgical correction of six patients with bifid nose by a combined Millard forked flap with external rhinoplasty
RESULTS: The aesthetic and functional outcomes were acceptable for all patients and parents. There were no considerable postoperative complications.
CONCLUSIONS: This approach is highly effective for various grades of bifid nose. Early management is preferable to avoid psychological morbidity. Secondary rhinoplasty is usually needed for cosmetic refinement.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bifid nose; Surgery; Tessier No:0 cleft

Mesh:

Year:  2016        PMID: 27260584     DOI: 10.1016/j.ijporl.2016.04.004

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Morphological Analysis of Nose in Patients of Tessier No. 0 Cleft With a Bifid Nose in China.

Authors:  Xin Wang; Huan Wang; Jianjun You; Ruobing Zheng; Yihao Xu; Xulong Zhang; Junsheng Guo; Fei Fan
Journal:  Front Pediatr       Date:  2021-11-29       Impact factor: 3.418

2.  Craniofacial development in patients of Tessier No.0 cleft with a bifid nose using 3D computed tomography.

Authors:  Xin Wang; Huan Wang; Jianjun You; Ruobing Zheng; Yihao Xu; Fei Fan
Journal:  Front Pediatr       Date:  2022-08-24       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.